eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Comorbidity | C0036341|schizophrenia |
| Sentences | 52 |
| PubMedID- 24204153 | Sod2 also plays crucial roles in antioxidant defense mechanisms.31 the val16ala polymorphism has been linked to cardiovascular disease and to type 2 diabetes and its complications in the general population, but studies so far have yielded conflicting results.28,29,33 in the present study, we did not find any significant associations between the sod2 genotype and the risks of being overweight and having metabolic syndrome in patients with schizophrenia or controls. |
| PubMedID- 23882141 | Purpose: to identify the point prevalence of metabolic syndrome in patients with schizophrenia and to evaluate the association between depressive symptoms and metabolic syndrome in patients with schizophrenia. |
| PubMedID- 20683849 | The objective of this multinational, cross-sectional, pharmacoepidemiological study was to determine the prevalence of diabetes, lipid disorders, obesity, hypertension and the metabolic syndrome in patients with schizophrenia treated with antipsychotic drugs. |
| PubMedID- 22592510 | A possible stratification of the risk of metabolic syndrome in patients with schizophrenia receiving atypical antipsychotic drugs is as follows: minimal-risk societies are constituted by societies living in eastern asian countries, whereas intermediate-risk societies are constituted by societies living in western asia and south america, and high-risk societies are societies living in australia. |
| PubMedID- 22747854 | Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in singapore. |
| PubMedID- 22154487 | [metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake]. |
| PubMedID- 23960421 | Despite expected controversies, some patient-related risk factors for the development of metabolic syndrome in patients with schizophrenia receiving atypical antipsychotic drugs are found in the literature. |
| PubMedID- 21105277 | The prevalence of the metabolic syndrome is increased in patients with schizophrenia compared with the general population. |
| PubMedID- 21791046 | This study aimed to investigate the degree that antipsychotic polypharmacy contributed to metabolic syndrome in outpatients with schizophrenia, after adjustment for the effects of lifestyle. |
| PubMedID- 21772644 | Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics. |
| PubMedID- 22044502 | Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a german observational study. |
| PubMedID- 25034455 | Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics. |
| PubMedID- 24837425 | metabolic syndrome is associated with both schizophrenia and antipsychotic medication, especially clozapine, with alterations in inflammatory cytokines and adipokines. |
| PubMedID- 22120854 | Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (cures-104). |
| PubMedID- 24955550 | Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study. |
| PubMedID- 26090224 | The prevalence of metabolic syndrome among individuals with schizophrenia varied between 19 and 29%, depending on the measurement criteria [66, 67], and 45% had insulin resistance [68]. |
| PubMedID- 21994515 | Genetic polymorphisms in the htr2c and peroxisome proliferator-activated receptors are not associated with metabolic syndrome in patients with schizophrenia taking clozapine. |
| PubMedID- 22503355 | Prevalence of metabolic syndrome in patients with schizophrenia in india. |
| PubMedID- 24682777 | There is no doubt that antipsychotic treatment is strongly associated with the development of metabolic syndrome in schizophrenia (hasnain et al. |
| PubMedID- 20850274 | Prevalence of metabolic syndrome among patients with schizophrenia in japan. |
| PubMedID- 25126357 | Objectives: to summarize the current literature on atypical antipsychotic-induced metabolic syndrome in patients with schizophrenia, outline some of the molecular mechanisms behind this syndrome, identify demographic and disease-related risk factors, and describe cost-effective methods for surveillance. |
| PubMedID- 21477998 | Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the clamors study. |
| PubMedID- 23138143 | Prevalence of metabolic syndrome among patients with schizophrenia in singapore. |
| PubMedID- 25917886 | The principal objective of this study was to investigate the relationship between sensory gating deficit and metabolic syndrome in patients with schizophrenia, after adjusting for key confounding factors. |
| PubMedID- 26093599 | [the stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial]. |
| PubMedID- 23270504 | Prevalence of metabolic syndrome among patients with schizophrenia in palestine. |
| PubMedID- 21398211 | In this article i review the theoretical and practical aspects of the comorbidity of schizophrenia with metabolic syndrome and diabetes mellitus. |
| PubMedID- 22841467 | [metabolic syndrome in patients with schizophrenia and antipsychotic treatment]. |
| PubMedID- 23341251 | Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate. |
| PubMedID- 22754543 | Finally, preliminary evidence suggests that folate supplementation, which may restore balance of the aldo met cycle, improves endothelial function in schizophrenia patients with metabolic syndrome (ellingrod et al., 2012). |
| PubMedID- PMC2945179 | The prevalence of metabolic syndrome among people with schizophrenia was 36.6% in men and 54.2% in women (21), far above the levels of 25.1% and 19.7%, respectively, in the overall u.s. population. |
| PubMedID- 23286356 | schizophrenia patients with metabolic syndrome (mets) (35%) had a 23.9% lower (p<0.001) sbj-score and 22.4% (p<0.001) lower 6mwt-score than those without mets. |
| PubMedID- 24891713 | Its effectiveness, both for positive and negative symptom schizophrenia with lower chances of metabolic syndrome, will help psychiatrists to treat schizophrenic and related disorders more effectively. |
| PubMedID- 26004686 | We aimed to determine the prevalence of metabolic syndrome among patients with schizophrenia who were antipsychotic drug-naive or drug-free and their siblings for comparison with healthy controls. |
| PubMedID- 24249923 | To help the psychiatrists to focus more on these cardiovascular risks in patients with schizophrenia, the concept of metabolic syndrome (mets) has received a lot of attention in psychiatric literature. |
| PubMedID- 20923919 | A uk systematic review and meta-analysis examined the relative risk of diabetes, dyslipidaemia, hypertension and metabolic syndrome in people with smi including schizophrenia (osborn et al., 2008). |
| PubMedID- 22438935 | In patients suffering from schizophrenia, a high incidence of metabolic syndrome or coronary heart disease (chd) have frequently been reported [1], [2]. |
| PubMedID- 22796278 | Moreover, strategies to reduce inflammation and obesity may prevent metabolic syndrome in patients with schizophrenia who take atypical antipsychotic medication. |
| PubMedID- 21185157 | Association between htr2c polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. |
| PubMedID- 20425584 | metabolic syndrome associated with schizophrenia and atypical antipsychotics. |
| PubMedID- 22970386 | To improve quality of life and decrease metabolic syndrome in patients with schizophrenia, it is essential for caregivers to support patients' drug administration with a minimal effective dose, and aripiprazole is considered to be one of the most effective options available. |
| PubMedID- 25568478 | Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit. |
| PubMedID- 22903391 | Lurasidone’s low propensity for weight gain and minimal effect on glucose and lipid parameters may be an important treatment consideration, especially in light of the increased rate of metabolic syndrome among patients with schizophrenia (correll et al. |
| PubMedID- 24647221 | The aim of this study was to investigate the characteristics of cognitive function damage in chronic schizophrenia patients with metabolic syndrome (ms); 388 patients were divided into two groups: ms group (180 people with schizophrenia and ms) and non-ms group (208 people with schizophrenia but without ms). |
| PubMedID- 25762938 | metabolic syndrome in schizophrenia patients can be partially explained as a side-effect of antipsychotic medications (448). |
| PubMedID- 25878665 | The rate of metabolic syndrome and diabetes in patients with schizophrenia is higher than the general population. |
| PubMedID- 22926590 | Higher prevalence rates of metabolic syndrome (mets) in patients with schizophrenia are getting more and more attention. |
| PubMedID- 22541717 | Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. |
| PubMedID- 22986004 | schizophrenia is statistically associated with metabolic syndrome, hypertension, and migraine because they form a cluster of diseases with similar pathophysiology. |
| PubMedID- 23528272 | In people with schizophrenia, rates of obesity and the metabolic syndrome are high compared to the general population. |
Page: 1 2